Comparative strategies to induce long-term graft acceptance in fully allogeneic renal versus cardiac allograft models by CD28-B7 T cell costimulatory blockade: Role of thymus and spleen

Journal of the American Society of Nephrology

Volumn 9, Issue 5, 1998, Pages 891-898

  Schaub, Meike ^a,b   Stadlbauer, Thomas H W ^a,b   Chandraker, Anil ^a,b   Vella, John P ^a,b   Turka, Laurence A ^c   Sayegh, Mohamed H ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HYBRID PROTEIN;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RAT; SPLEEN; T LYMPHOCYTE ACTIVATION; THYMUS;

EID: 0031960157     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Krensky A, Weiss A, Crabtree G, Davis M, Parham P: T-lymphocyte-antigen interactions in transplant rejection. N Engl J Med 322: 510-517, 1990
2. Janeway CA, Bottomly K: Signals and signs for lymphocyte responses. Cell 76: 275-285, 1994
3. Schwartz RH: Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065-1068, 1992
4. Linsley PS, Ledbetter JA: The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11: 191-212, 1993
5. June CH, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor families. Immunol Today 15: 321-331, 1994
6. Bluestone JA: New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2: 555-559, 1995
7. Thompson CB: Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation. Cell 81: 979-982, 1995
8. Gimmi CD, Freeman GJ, Gribben JG, Gray G, Nadler LM: Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 90: 6586-6590, 1993
9. Tan P, Anasetti C, Hansen JA, Melrose J, Brunvand M, Bradshaw J, Ledbetter JA, Linsley PS: Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med 177: 165-173, 1993
10. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA: CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 174: 561-569, 1991
11. Sayegh MH, Turka LA: T cell costimulatory pathways: Promising novel targets for immunosuppression and tolerance induction. J Am Soc Nephrol 6: 1143-1150, 1995
12. Akalin E, Chandraker A, Sayegh MH, Turka LA: Role of the CD28:B7 costimulatory interaction in alloimmune responses. Kidney Int [Suppl]: S8-S10, 1997
13. Turka LA, Linsley PS, Lin H, Brady W, Leiden JM, Wei RQ, Gibson ML, Zheng XG, Myrdal S, Gordon D, Bailey T, Bolling SF, Thompson CB: T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 89: 11102-11105, 1992
14. Lin H, Bolling SF, Linsley PS, Wei RQ, Gordon D, Thompson CB, Turka LA: Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med 178: 1801-1806, 1993
15. Pearson TC, Alexander DZ, Winn KJ, Linsley PS, Lowry RP, Larsen CP: Transplantation tolerance induced by CTLA4-Ig. Transplantation 57: 1701-1706, 1994
16. Pearson T, Alexander D, Hendrix R, Elwood E PS L, Winn K, Larsen C: CTLA4-Ig plus bone marrow induces long-term allograft survival, donor-specific unresponsiveness in the murine model: Evidence for hematopoietic chimerism. Transplantation 61: 997-1004, 1995
17. Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB, Turka LA: CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 181: 1869-1874, 1995
18. Perico N, Imberti O, Bontelpelli M, Remuzzi G: Toward novel antirejection strategies: In vivo immunosuppressive properties of CTLA4Ig. Kidney Int 47: 241-246, 1995
19. Russell ME, Hancock WW, Akalin E, Wallace AF, Glysing-Jensen T, Willett T, Sayegh MH: Chronic cardiac rejection in the Lewis to F344 rat model: Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell, macrophage activation, attenuates arteriosclerosis. J Clin Invest 97: 833-838, 1996
20. Azuma H, Chandraker A, Nadeau K, Hancock WW, Carpenter CB, Tilney NL, Sayegh MH: Blockade of T cell costimulation prevents development of experimental chronic allograft rejection. Proc Natl Acad Sci USA 93: 12439-12444, 1996
21. Remuzzi G, Perico N, Carpenter CB, Sayegh MH: The thymic way to transplantation tolerance. J Am Soc Nephrol 5: 1639-1646, 1995
22. Naji A: Induction of tolerance by intrathymic inoculation of alloantigen. Curr Opin Immunol 8: 704-709, 1996
23. Qin S, Cobbold S, Pope H, Elliott J, Kioussis D, Davies J, Waldmann H: "Infectious" transplantation tolerance. Science 259: 974-976, 1993
24. Onodera K, Lehmann M, Akalin E, Volk HD, Sayegh MH, Kupiec-Weglinski JW: Induction of infectious tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J Immunol 157: 1944-1950, 1996
25. Sayegh MH, Sablinski T, Tanaka K, Kut JP, Kwok CA, Tilney NL, Kupiec-Weglinski JW, Milford EL: Effects of BWH-4 anti-CD4 monoclonal antibody on rat vascularized cardiac allografts before and after engraftment. Transplantation 51: 296, 1991
26. Chandraker A, Russell ME, Glysing-Jensen T, Willett TA, Sayegh MH: T cell costimulatory blockade in experimental chronic cardiac allograft rejection: Effects of cyclosporine and donor antigen. Transplantation 63: 1053-1058, 1997
27. Khoury SJ, Gallon L, Verburg RR, Chandraker A, Peach R, Linsley PS, Turka LA, Hancock WW, Sayegh MH: Ex-vivo treatment of antigen presenting cells with CTLA4Ig and encephalitogenic peptide prevents experimental autoimmune encephalomyelitis in the Lewis rat. J Immunol 157: 3700-3705, 1996
28. Adams DH, Russell WW, Hancock WW, Sayegh MH, Wyner LR, Karnovsky MJ: Chronic rejection in experimental cardiac transplantation: Studies in the Lewis-F344 model. Immunol Rev 134: 7-19, 1993
29. Akalin E, Chandraker A, Russell MA, Turka LA, Hancock WW, Sayegh MH: Mechanisms of tolerance to renal allografts by CTLA41g: Inhibition of cell mediated and humoral immune responses in vivo. Transplantation 62: 1942-1945, 1996
30. Steurer W, Nickerson PW, Steele AW, Steiger J, Zheng X, Strom TB: Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance. J Immunol 155: 1165-1174, 1995
31. Carpenter CB: Long-term failure of renal transplants: Adding insult to injury. Kidney Int 48: S40-S44, 1995
32. Paul L: Chronic renal transplant loss. Kidney Int 47: 1491-1499, 1995
33. Judge TA, Tang A, Spain LM, Gratiot-Deans J, Sayegh MH, Turka LA: The in vivo mechanisms of action of CTLA4Ig. J Immunol 156: 2294-2299, 1996
34. Larsen CP, Ritchie SC, Hendrix R, Linsley PS, Hathcock KS, Hodes RJ, Pearson TC: Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol 152: 5208-5219, 1994
35. Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ: Comparative analysis of B7-1 and B7-2 costimulatory ligands: Expression and function. J Exp Med 180: 631-640, 1994
36. Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA: Costimulatory function and expression of CD40 ligand, CD80 and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 93: 13967-13972, 1996
37. Walunas TL, Bakker CY, Bluestone JA: CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 183: 2541-2550, 1996
38. Perez V, Parijs LV, Biuckians A, Zheng X, Strom T, Abbas A: Induction of peripheral T cell tolerance in vivo required CTLA-4 engagement. Immunity 6: 411-417, 1997
39. Lu L, McCaslin D, Starzl TE, Thomson AW: Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 60: 1539-1545, 1995
40. Sayegh MH, Watschinger B, Carpenter CB: Mechanisms of T cell recognition of alloantigen: The role of peptides. Transplantation 57: 1295-1302, 1994
41. Adams DH, Tilney NL, Collins JJ, Karnovsky MJ: Experimental graft arteriosclerosis. I. The Lewis-to-F344 allograft model. Transplantation (Baltimore) 53: 1115-1119, 1992
42. Hancock WW, Whitley WD, Tullius SG, Heeman U, Wasowska B, Baldwin WM, Tilney NL: Cytokines, adhesion molecules and the pathogenesis of chronic rejection of renal allografts. Transplantation 56: 643-650, 1993
43. Russell ME, Wallace AF, Hancock WW, Sayegh MH, Adams DH, Sibinga NES, Wyner LR, Karnovsky MJ: Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation 59: 572-578, 1995
44. Tullius SG, Tilney NL: Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 59: 313-318, 1995
45. Sayegh MH, Carpenter CB: Tolerance and chronic rejection. Kidney Int 51: S8-S10, 1997
46. Yamada K, Gianello PR, Ierino FL, Lorf T, Shimizu A, Meehan S, Colvin RB, Sachs DH: Role of the thymus in transplantation tolerance in miniature swine. I. Requirement of the thymus for rapid and stable induction of tolerance to class I-mismatched renal allografts. J Exp Med 186: 497-506, 1997
47. Lakkis F, Konieczny B, Saleem S, Baddoura F, Linsley P, Alexander D, Lowry R, Pearson T, Larsen C: Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4. J Immunol 158: 2443-2448, 1997
48. Nickerson P, Steiger J, Zheng X, Steele AW, Steurer W, Roy CP, Strom TB: Manipulation of cytokine networks in transplantation: False hope or realistic opportunity for tolerance? Transplantation 63: 489-494, 1997